LupusQoL-US benchmarks for US patients with systemic lupus erythematosus.

  title={LupusQoL-US benchmarks for US patients with systemic lupus erythematosus.},
  author={Meenakshi Jolly and Simon A Pickard and Rachel A. Mikolaitis and Roger A. Rodby and Winston Sequeira and Joel A. Block},
  journal={The Journal of rheumatology},
  volume={37 9},
OBJECTIVE The LupusQoL-US instrument was recently validated in the US. We studied the benchmarks for a US patient cohort with systemic lupus erythematosus (SLE) and relevant demographic and disease correlates. METHODS LupusQoL-US was administered to 185 patients with SLE. Demographic data (age, sex, ethnicity, marital status) and disease features (duration, disease activity and damage) were assessed simultaneously. Descriptive statistics were obtained. LupusQoL-US domain scores were… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…